FOR IMMEDIATE RELEASE
Thursday, Oct 7, 2004
Floyd E. Bloom, M.D.
Founding Chief Executive Officer
Neurome, Inc. Elects Khoury, Wender
to Board of Directors
LA JOLLA, CA, Oct. 7, 2004 – The Board of Directors
of Neurome, Inc., a privately held biotechnology company,
today announced the appointment of Michael Khoury and Joseph
Wender to its Board of Directors.
Joseph Wender is an Advisory Director and Senior Director
of the Financial Institutions Group at the global investment
banking firm, Goldman, Sachs & Co., and Michael Khoury
is a financial advisor and independent consultant. These additions
bring Neurome’s total Board membership to six.
Commenting on the new appointments to the Board, Floyd E.
Bloom, M.D., Chairman of the Board and Founding Chief Executive
Officer of Neurome, remarked, “Joe Wender and Michael
Khoury, both seasoned biotech investors and experienced financial
professionals, complement the strengths of our current Board.
We are gratified by their expressions of confidence in Neurome
and look forward to their important contributions to our evolution
as a leader in discovery and development of product solutions
for human neurodegenerative disease.”
Michael Khoury joined Deloitte & Touche, one of the nation’s
leading professional services firms, in 1989 and served as
Senior Manager until 1993. From 1993 to 1998 Mr. Khoury served
as first President, then CEO of First National Mortgage Exchange.
He was Senior Vice President at IMC Mortgage, a consumer finance
company, from 1998 to 1999. In 1999 he was appointed CEO of
InterScore, a consulting firm that he sold in 2000 to Ballantyne,
Inc., a consulting firm focused on Enterprise Resource Planning
systems, where he remained as a Senior Vice President until
2003. He holds a B.S. in Mathematics from the American University
of Beirut, an MFA from New York University, and an MBA from
UCLA. He is a CPA and a Fulbright Scholar.
Joseph H. Wender joined Goldman Sachs in 1971 and became
a General Partner of that firm in 1982 and a Limited Partner
in 1992. He has been involved in most large mergers in the
banking industry over the 80's and 90's, including the BankAmerica/Nations
merger, the Wells Fargo/Norwest merger, and the Chase/Chemical
merger. Mr. Wender sits on the board of Isis Pharmaceuticals,
First Coastal Bancshares, and Affinity Financial. He is the
President of the American Center for Wine, Food & the
Arts, and is a Life Director of The Chicago Joffrey Ballet
as well as a Member of the Board of Directors of the Actors’
Fund. Mr. Wender received his Bachelors degree from Northwestern
University, his LLB from Yale Law School, and his MBA from
Harvard Business School.
Neurome, Inc. is a discovery stage biotechnology company
that seeks therapeutic solutions to human neurodegenerative
diseases. The company focuses its efforts on Alzheimer's disease,
Parkinson's disease, Huntington's disease, and Amyotrophic
Lateral Sclerosis (ALS or Lou Gehrig’s disease) –
usually fatal neurodegenerative disorders that are currently
untreatable and share characteristics which make them particularly
amenable to Neurome's expertise and technologies.
Since its founding in 2000, Neurome has developed and optimized
proprietary technologies to reveal and quantify gene expression
patterns and the resultant morphological details of brain
structures in normal and pathological brains with an unprecedented
level of sensitivity, specificity and resolution. Neurome’s
unique technologies to measure and assess neurodegenerative
processes at work – at the molecular, cellular and macroscopic
levels – are ideally suited to identify the earliest
evidence of pathology in models of human diseases of the Central
Nervous System, as well as to evaluate the comparative effectiveness
of pharmaceutical candidates for intervention. The company
dedicates these technologies to discovery and development
of drugs to provide effective treatments for diseases characterized
by neurodegeneration. Detailed information on the Neurome
technologies and the scientific and medical challenges of
human neurodegenerative disorders are available at Neurome’s